- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05915611
Combined Physical and Psychological Intervention in Carpal Tunnel Syndrome Patients With Nociplastic Pain
June 14, 2023 updated by: Mohamed Magdy ElMeligie, Ahram Canadian University
Evaluating the Effectiveness of a Combined Physical and Psychological Intervention in Carpal Tunnel Syndrome Patients With Nociplastic Pain: A Randomized Controlled Trial
To assess the effectiveness of a combined physical and psychological intervention in reducing pain and improving function in carpal tunnel syndrome patients with nociplastic pain.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mohamed M ElMeligie, Ph.d
- Phone Number: +201064442032
- Email: mohamed.elmeligie@acu.edu.eg
Study Contact Backup
- Name: Amal Fawzy, Ph.d
- Phone Number: +201159880001
- Email: dr.amalfawzy@acu.edu.eg
Study Locations
-
-
Giza
-
Al Ḩayy Ath Thāmin, Giza, Egypt, 3221405
- Recruiting
- Outpatient clinic of faculty of physical therapy, Ahram Canadian University
-
Contact:
- Mohamed M ElMeligie, Ph.d
- Phone Number: 01064442032
- Email: mohamed.elmeligie@acu.edu.eg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Adults aged 25-65 years
- Both sexes
- Diagnosis of carpal tunnel syndrome based on clinical examination and nerve conduction studies
- Presence of nociplastic pain as determined by the Central Sensitization Inventory (CSI) with a score ≥40
- Positive tinel and phalen sign.
Exclusion Criteria:
- Previous carpal tunnel release surgery
- Other musculoskeletal or neurological disorders affecting the upper extremity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention group
Participants will receive a twelve-week combined physical and psychological intervention.
|
Physical therapy components will include splinting, tendon and nerve gliding exercises. Psychological components will include cognitive-behavioral therapy (CBT), delivered in individual sessions, targeting pain catastrophizing and fear of movement. Participants will attend 2 physical therapy sessions and one CBT session per week. for a period of 12 weeks |
|
Active Comparator: Control group
Participants will receive a twelve-week of standard care of splinting, tendon and nerve gliding exercises.
|
Participants will be asked to wear a prefabricated wrist splint during the night and during strenuous activity.
Also, they will receive tendon and nerve gliding exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pain intensity using the Numeric Pain Rating Scale (NPRS)
Time Frame: Changes in pain intensity at baseline, 6 weeks, 12 weeks.
|
Changes in pain intensity at baseline, 6 weeks, 12 weeks.
|
|
Functional ability using the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire
Time Frame: Changes in Functional ability at baseline, 6 weeks, 12 weeks.
|
Changes in Functional ability at baseline, 6 weeks, 12 weeks.
|
|
Median nerve motor distal latency
Time Frame: Changes in Median nerve motor distal latency at baseline, 6 weeks, 12 weeks.
|
Changes in Median nerve motor distal latency at baseline, 6 weeks, 12 weeks.
|
|
Median nerve sensory distal latency
Time Frame: Changes in Median nerve sensory distal latency at baseline, 6 weeks, 12 weeks.
|
Changes in Median nerve sensory distal latency at baseline, 6 weeks, 12 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pain catastrophizing using the Pain Catastrophizing Scale (PCS)
Time Frame: Changes in Pain Catastrophizing Scale (PCS) at baseline, 6 weeks, 12 weeks.
|
Changes in Pain Catastrophizing Scale (PCS) at baseline, 6 weeks, 12 weeks.
|
|
Fear of movement using the Tampa Scale for Kinesiophobia (TSK)
Time Frame: Changes in Tampa Scale for Kinesiophobia (TSK) at baseline, 6 weeks, 12 weeks.
|
Changes in Tampa Scale for Kinesiophobia (TSK) at baseline, 6 weeks, 12 weeks.
|
|
Grip strength measured using a hand dynamometer
Time Frame: Changes in Grip strength at baseline, 6 weeks, 12 weeks.
|
Changes in Grip strength at baseline, 6 weeks, 12 weeks.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Amal Fawzy, Ph.d, Faculty of Physical Therapy, Ahram Canadian University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 27, 2023
Primary Completion (Estimated)
September 27, 2024
Study Completion (Estimated)
September 27, 2024
Study Registration Dates
First Submitted
June 14, 2023
First Submitted That Met QC Criteria
June 14, 2023
First Posted (Actual)
June 23, 2023
Study Record Updates
Last Update Posted (Actual)
June 23, 2023
Last Update Submitted That Met QC Criteria
June 14, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Nervous System Diseases
- Pain
- Neurologic Manifestations
- Wounds and Injuries
- Disease
- Neuromuscular Diseases
- Mononeuropathies
- Peripheral Nervous System Diseases
- Median Neuropathy
- Nerve Compression Syndromes
- Cumulative Trauma Disorders
- Sprains and Strains
- Syndrome
- Carpal Tunnel Syndrome
- Chronic Pain
Other Study ID Numbers
- 012/CTS/120002023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.